Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Mar 25;16(3):e0247829. doi: 10.1371/journal.pone.0247829

Impact of onset-to-door time on outcomes and factors associated with late hospital arrival in patients with acute ischemic stroke

Eung-Joon Lee 1,, Seung Jae Kim 2,3,, Jeonghoon Bae 1, Eun Ji Lee 4, Oh Deog Kwon 5, Han-Yeong Jeong 1, Yongsung Kim 6, Hae-Bong Jeong 6,*
Editor: Miguel A Barboza7
PMCID: PMC7993794  PMID: 33765030

Abstract

Background and purpose

Previous studies have reported that early hospital arrival improves clinical outcomes in patients with acute ischemic stroke; however, whether early arrival is associated with favorable outcomes regardless of reperfusion therapy and the type of stroke onset time is unclear. Thus, we investigated the impact of onset-to-door time on outcomes and evaluated the predictors of pre-hospital delay after ischemic stroke.

Methods

Consecutive acute ischemic stroke patients who arrived at the hospital within five days of onset from September 2019 to May 2020 were selected from the prospective stroke registries of Seoul National University Hospital and Chung-Ang University Hospital of Seoul, Korea. Patients were divided into early (onset-to-door time, ≤4.5 h) and late (>4.5 h) arrivers. Multivariate analyses were performed to assess the effect of early arrival on clinical outcomes and predictors of late arrival.

Results

Among the 539 patients, 28.4% arrived early and 71.6% arrived late. Early hospital arrival was significantly associated with favorable outcomes (three-month modified Rankin Scale [mRS]: 0−2, adjusted odds ratio [aOR]: 2.03, 95% confidence interval: [CI] 1.04–3.96) regardless of various confounders, including receiving reperfusion therapy and type of stroke onset time. Furthermore, a lower initial National Institute of Health Stroke Scale (NIHSS) score (aOR: 0.94, 95% CI: 0.90–0.97), greater pre-stroke mRS score (aOR: 1.58, 95% CI: 1.18–2.13), female sex (aOR: 1.71, 95% CI: 1.14–2.58), unclear onset time, and ≤6 years of schooling (aOR: 1.76, 95% CI: 1.03–3.00 compared to >12 years of schooling) were independent predictors of late arrival.

Conclusions

Thus, the onset-to-door time of≤4.5 h is crucial for better clinical outcome, and lower NIHSS score, greater pre-stroke mRS score, female sex, unclear onset times, and ≤6 years of schooling were independent predictors of late arrival. Therefore, educating about the importance of early hospital arrival after acute ischemic stroke should be emphasized. More strategic efforts are needed to reduce the prehospital delay by understanding the predictors of late arrival.

Introduction

Acute ischemic stroke is an emergency situation, and delayed treatment often leads to death or disability [1, 2]. The administration of intravenous tissue plasminogen activator (IV-tPA) within 4.5 h or performing mechanical thrombectomy within 24 h of stroke onset has been established as the most effective treatment, resulting in better clinical outcomes [3, 4]. However, since the eligibility for reperfusion therapy is highly dependent on stroke onset time [5], very few patients, including those who arrive at the hospital late or those with unclear onset time, miss the opportunity to receive such therapies [6, 7]. Early hospital arrival after acute ischemic stroke is also important for those who are eligible for reperfusion therapy because the sooner the hospital arrival, the better the efficacy of reperfusion therapy [8, 9]. However, despite the constant efforts to shorten the onset-to-door time of ischemic stroke, the proportion of eligible patients for reperfusion therapy has remained low, as many patients are still unable to receive this therapy [1012].

Previous studies showed that early hospital arrival was a significant factor for better functional outcomes [1315]. However, patients who received reperfusion therapy during the acute phase were included in most of these studies; therefore, better outcomes of early arrivers might be owing to reperfusion therapy. Additionally, since the reperfusion therapy is provided based on patients’ last known well time, patients with unclear-onset stroke are less likely to receive reperfusion therapy [16]. Therefore, there is a lack of knowledge regarding whether arriving at a hospital early with unclear-onset stroke will benefit patients. That is, evidence regarding the association between early hospital arrival and better clinical outcomes in patients with ischemic stroke regardless of reperfusion therapy or the type of stroke onset time (clear- or unclear-onset strokes) is relatively limited.

To address this issue, we assessed the onset-to-door time in patients with acute ischemic stroke based on data from two large stroke centers in Korea. This study aimed to investigate whether early hospital arrival (onset-to-door time ≤4.5 h) is independently associated with favorable functional outcomes regardless of various potential factors, including receiving reperfusion therapy and the type of stroke onset time (clear- or unclear-onset strokes), that could affect the outcome. We also identified factors associated with late hospital arrival after acute ischemic stroke to offer a meaningful perspective to reduce pre-hospital delays.

Methods

Study institutions and population

Data for this two-center retrospective cohort study were obtained from the prospective stroke registries of Seoul National University Hospital (SNUH) and Chung-Ang University Hospital (CAUH). SNUH is a 1,750-bed university tertiary-referral hospital located in north-central Seoul. CAUH is also a university tertiary-referral hospital with 800 beds located in southwest Seoul, the capital of the Republic of Korea. Both stroke centers of the SNUH and CAUH fulfilled the major requirements of the comprehensive stroke center as defined by the Brain Attack Coalition [17]. A total of 692 consecutive patients with acute ischemic stroke who arrived at the emergency room of each hospital within five days of stroke symptom onset from September 2019 to May 2020 were included in the study. Patients who arrived via transfer from another hospital and whose three-month modified Rankin scale (mRS) scores were not available were excluded. In effect, the final study population was 539 patients (332 from SNUH and 207 from CAUH, Fig 1). Our study was approved by the institutional review boards (IRBs) of both the SNUH (IRB Number: 1009-062-332) and CAUH (IRB Number: 1912-005-359); the requirement for written consent was waived by the IRBs.

Fig 1. Flowchart of the selection process of participants.

Fig 1

SNUH, Seoul National University Hospital; CAUH, Chung-Ang University Hospital.

Study variables and groups

The onset time of stroke, time of arrival at the hospital, sociodemographic data (sex, age, years of schooling), conventional vascular risk factors (history of hypertension, diabetes mellitus [DM], dyslipidemia, atrial fibrillation [AF], previous ischemic stroke or transient ischemic attack [TIA], coronary artery disease [CAD], and smoking status), medication history of antithrombotics (antiplatelet or anticoagulation agents), initial National Institute of Health Stroke Scale (NIHSS) score, pre-stroke mRS score, the status of receiving acute reperfusion therapy (IV-tPA administration or mechanical thrombectomy), and the details of hospital arrival, including daytime or nighttime arrival, of each patient were collected from the database of each hospital’s stroke registry. Regarding the indicators of clinical outcomes of patients, the length of hospital stay, mRS scores at discharge, and mRS scores at three months after stroke were gathered. The onset time of stroke was defined as the time when the patient or bystander first noticed the stroke symptoms. For patients with uncertain onset time, the last known asymptomatic time was considered as the onset time. The hospital arrival time was categorized into daytime (07:01−21:00) and nighttime (21:00−07:00) according to the visit hours during the day. For smoking status, patients were categorized as either current smokers or non-smokers (never or past smokers). Patients were dichotomized into two groups: the early arrival group (time from symptom onset to hospital arrival ≤4.5 h) and the late arrival group (time from symptom onset to hospital arrival >4.5 h). We selected 4.5 h as the cut-off point for categorizing early and late arrivers to reflect the current 4.5-h limit of IV-tPA administration [3].

Predictors of delayed onset-to-door time and favorable outcomes

We included sex, age, educational status, the type of stroke onset time (clear- or unclear-onset strokes), medical histories (pre-stroke mRS score, comorbidities, previous stroke or TIA, previous use of antithrombotics, and smoking status), initial NIHSS score, and arrival time (daytime or nighttime) as potential factors that could affect the delayed onset-to-door time. Regarding the factors associated with favorable clinical outcome, age, educational status, the type of stroke onset time (clear- or unclear-onset strokes), medical histories (pre-stroke mRS score, comorbidities, previous stroke or TIA, previous use of antithrombotics and smoking status), initial NIHSS score, early hospital arrival (≤4.5 h), arrival time (daytime or nighttime), and receiving reperfusion therapy were included for the analysis. Both the pre-stroke mRS and initial NIHSS scores were included as continuous variables.

Statistical analyses

The characteristics and outcome variables were presented as numbers, percentages, and means with corresponding standard deviations. We performed the independent sample t-test or Mann-Whitney U test for continuous variables, and chi square test or Fisher’s exact test for categorical variables to compare the characteristics and outcome variables between the early and late arrival groups. With delayed arrival to a hospital (>4.5 h) as the dependent variable, univariate analysis was performed, followed by an adjusted multivariate logistic regression analysis for investigating the predictors of pre-hospital delay. Furthermore, univariate and multivariate logistic regression analyses were performed to examine the association between early hospital arrival and favorable outcomes. We included variables with p-values <0.1 in the univariate analysis for the multivariate analysis. All statistical analyses were performed using SPSS version 25 (IBM Corp., Armonk, NY, USA). A two-sided p-value of <0.05 was considered statistically significant.

Results

Baseline characteristics of patients

Among the 539 patients with ischemic stroke, 153 (28.4%) arrived at the hospital within 4.5 h of stroke onset, while 386 (71.6%) patients arrived at the hospital after 4.5 h. The mean age of patients was 68.3 ± 13.1 years. The mean onset-to-door time of all patients was 1761.31 ± 2217.91 min, whereas the mean onset-to-door time for the early and late arrival groups were 100.38 ± 68.72 min and 2,419.64 ± 2,311.10 min, respectively. Most patients (82.4%) arrived at the hospital during the daytime. Among all patients, 55.1% were men and 43.6% had unclear stroke onset. Regarding educational status, 33.9% of the patients had ≤6 years of schooling, 42.5% had 7−12 years of schooling, and the remaining 23.6% had >12 years of schooling. Regarding comorbidities, 56.0% of the patients had hypertension, 34.1% had DM, 46.9% had dyslipidemia, 19.3% had AF, and 14.3% had CAD. Those with a history of ischemic stroke or TIA accounted for 24.9% of the patients, and 43.6% had a history of antithrombotics use. Current smokers accounted for 29.3% of the patients, and 70.7% were either never smokers or past smokers. Regarding the severity of stroke and pre-stroke disability, the average initial NIHSS score was 4.59 ± 5.65, and the average pre-stroke mRS score was 0.33 ± 0.96. Of the total ischemic stroke patients, 8.2% received intravenous thrombolysis, and 9.1% underwent mechanical thrombectomy. Regarding clinical outcomes, the average length of hospitalization was 11.21 ± 14.34 days, and the average NIHSS score, mRS score at discharge, and three-month mRS score were 3.39 ± 6.19, 1.88 ± 1.46, and 1.79 ± 1.48, respectively. Furthermore, seven patients died within three months since the event, and all of them were late arrivers. The early arrivers were more likely to be younger, men, more educated and have clear-onset stroke, lesser pre-stroke disability, greater severity of the stroke, and better mRS score at discharge and three-month mRS score. The differences in other variables between the early and late arrivers were not statistically significant (Table 1).

Table 1. Baseline characteristics of patients according to onset-to-door time.

Characteristics All n (%) or mean ± SD Onset-to-door time p-value
Early arrival group (0–4.5 h) n (%) or mean ± SD Late arrival group (>4.5 h) n (%) or mean ± SD
Total 539 (100%) 153 (100%) 386 (100%)
Socio-demographic factors
    Sex 0.004
        Male 297 (55.1%) 99 (64.7%) 198 (51.3%)
        Female 242 (44.9%) 54 (35.3%) 188 (48.7%)
    Age (years) 68.3±13.05 66.47±11.89 69.02±13.43 0.041
        <50 43 (8.0%) 13 (8.5%) 30 (7.8%)
        50−59 80 (14.8%) 26 (16.9%) 54 (13.9%)
        60−69 143 (26.5%) 46 (30.1%) 97 (25.1%)
        70−79 168 (31.2%) 49 (32.0%) 119 (30.8%)
        ≥80 105 (19.5%) 19 (12.4%) 86 (22.3%)
    Years of schooling 0.023
        0−6 years 183 (33.9%) 40 (21.9%) 144 (37.3%)
        7−12 years 229 (42.5%) 68 (44.4%) 161 (41.7%)
        >12 years 127 (23.6%) 45 (29.4%) 81 (21.0%)
Type of stroke onset time 0.000
        Clear 304 (56.4%) 110 (71.9%) 194 (50.3%)
        Unclear 235 (43.6%) 43 (28.1%) 192 (49.7%)
Medical history
        Previous mRS score 0.33±0.96 0.16±0.67 0.40±1.04 0.001
        Comorbidities
            Hypertension 377 (69.9%) 109 (71.2%) 268 (69.4%) 0.813
            Diabetes mellitus 184 (34.1%) 53 (34.6%) 131 (33.9%) 0.759
            Dyslipidemia 253 (46.9%) 76 (49.6%) 177 (45.8%) 0.424
            Atrial fibrillation 104 (19.3%) 32 (20.9%) 72 (18.7%) 0.549
            Coronary artery disease 77 (14.3%) 27 (17.6%) 50 (13%) 0.185
        Previous ischemic stroke or TIA 0.318
            Yes 134 (24.9%) 42 (27.5%) 92 (23.93%)
            No 405 (75.1%) 111 294
    Previous use of antithromboticsa 0.475
            Yes 235 (43.6%) 63 (41.2%) 172 (44.6%)
            No 304 (56.4%) 90 214
        Smoking status 0.653
            Current smoker 158 (29.3%) 47 (30.7%) 111 (28.8%)
            Non-smoker (never/past smoker) 381 (70.7%) 106 275
    Initial NIHSS score 4.59±5.65 5.55±6.70 4.22±5.14 0.028
Acute reperfusion therapy
    IV-tPA 44 (8.2%) 44 (28.8%) 0 (0.0%) 0.000
    IA thrombectomy 49 (9.1%) 29 (19.0%) 20 (5.2%) 0.000
Outcomes
    Length of hospital stay 11.21±14.34 12.89±32.72 10.55±12.29 0.390
    NIHSS score at discharge 3.39±6.19 2.78±4.41 3.63±6.76 0.149
    mRS score at discharge 1.88±1.46 1.64±1.37 1.98±1.48 0.016
    mRS score at 3 months 1.79±1.48 1.33±1.36 1.89±1.48 0.000
    Mortality at 3 months 7 (1.30%) 0 (0%) 7 (0.02%) 0.200
Arrival time
    Arrival at daytime (7 AM−9 PM) 444 (82.4%) 122 (79.7%) 322 (83.4%) 0.330
    Arrival at nighttime (9 PM−7 AM) 95 (17.6%) 31 (20.3%) 64 (16.6%) 0.314
    Mean onset-to-door time (mins) 1761.31±2217.91 100.38±68.72 2419.64±2311.10 0.000

Abbreviations: SD, standard deviation; mRS, modified Rankin Scale; TIA, transient ischemia stroke; IV, intravenous; tPA tissue plasminogen activator; IA, intra-arterial; NIHSS, National Institute of Health Stroke Scale; AM, ante meridiem; PM, post meridiem.

aAntiplatelets or anticoagulation agents.

Factors associated with delayed onset-to-door time

The results of the multivariate logistic regression analysis of factors associated with delayed onset-to-door time (>4.5 h) are presented in Table 2. Female sex (adjusted odds ratio [aOR]: 1.71, 95% confidence interval [CI]: 1.14−2.58) and a higher previous mRS score (aOR: 1.58, 95% CI: 1.18−2.13) were significantly associated with delayed onset-to-door time. However, clear-onset stroke (aOR: 0.35, 95% CI: 0.22−0.53) and a higher initial NIHSS score (aOR: 0.94, 95% CI: 0.90−0.97) showed a negative significant correlation with late hospital arrival. For educational status, low educational level (0−6 years of schooling) (aOR: 1.76, 95% CI: 1.03−3.00) was significantly associated with late hospital arrival than high educational level (>12 years); however, no significant association was found between intermediate (7−12 years) and high educational levels. Other factors, including age, comorbidities (hypertension, DM, AF, and CAD), smoking status, history of stroke or TIA, previous use of antithrombotics, and arrival at daytime or nighttime, were not significantly associated with delayed onset-to-door time. The multivariate model showed a good fit (Hosmer–Lemeshow test: P = 0.689).

Table 2. Factors associated with delayed onset-to-door time (> 4.5 h).

Univariate analysis (n = 539) Multivariate analysis (n = 539)
Factors Unadjusted OR (95% CI) p-value Adjusted ORa (95% CI) p-value
Female sex 1.74 (1.18–2.56) 0.005 1.71 (1.14–2.58) 0.010
Age (years) 1.02 (1.00–1.03) 0.042 1.01 (0.99–1.03) 0.267
Education
    >12 years ref ref
    7–12 years 1.32 (0.83–2.09) 0.245 1.18 (0.70–1.86) 0.606
    0–6 years 2.00 (1.21–3.32) 0.007 1.76 (1.03–3.00) 0.017
Clear onset 0.40 (0.26–0.59) 0.000 0.35 (0.22–0.53) 0.000
Previous mRS score 1.44 (1.09–1.90) 0.011 1.58 (1.18–2.13) 0.003
Hypertension 0.95 (0.63–1.44) 0.812 - -
Diabetes mellitus 0.98 (0.65–1.44) 0.877 - -
Dyslipidemia 0.86 (0.59–1.25) 0.423 - -
Atrial fibrillation 0.87 (0.54–1.38) 0.549 - -
Coronary artery disease 0.69 (0.42–1.16) 0.162 - -
Current smoker 0.91 (0.61–1.37) 0.652 - -
Previous ischemic stroke or TIA 0.79 (0.52–1.21) 0.273 - -
Previous use of antithromboticsb 1.15 (0.79–1.68) 0.475 - -
Initial NIHSS score 0.96 (0.93–0.99) 0.015 0.94 (0.90–0.97) 0.000
Arrival at daytime 1.28 (0.79–2.06) 0.313 - -
Arrival at nighttime 0.77 (0.48–1.24) 0.278 - -

aAdjusted for sex, age, educational status, type of stroke onset time (clear- or unclear-onset strokes), previous mRS score, initial NIHSS score.

bAntiplatelets and anticoagulation agents.

Abbreviations: OR, odds ratio; CI, confidence interval; mRS, modified Rankin Scale; TIA, transient ischemic stroke; NIHSS, National Institute of Health Stroke Scale.

Factors associated with a favorable outcome (3-month mRS score: 0−2)

The results of the multivariate logistic regression analysis of the predictors of favorable outcome (three-month mRS: 0−2) are presented in Table 3. Overall, early hospital arrival within 4.5 h was the most prominent factor (aOR: 2.03, 95% CI: 1.04−3.96) that significantly correlated with a favorable three-month mRS score. Moreover, older age (aOR: 0.97, 95% CI: 0.95−0.99), higher previous mRS score (aOR: 0.52, 95% CI: 0.38−0.69), and initial NIHSS score (aOR: 0.77, 95% CI: 0.73−0.82) had a significant negative association with favorable outcomes. Other factors, including age, educational level, comorbidities (hypertension, DM, AF, and CAD), previous ischemic stroke or TIA, previous use of antithrombotics, acute thrombolysis therapy, and arrival at daytime or nighttime, had no significant correlation with a favorable three-month mRS. The multivariate model showed a good fit (Hosmer–Lemeshow test: p-value = 0.756).

Table 3. Factors associated with a favorable outcome (3-month mRS score: 0–2).

Univariate analysis (n = 539) Multivariate analysis (n = 539)
Factors OR (95% CI) p-value Adjusted ORa (95% CI) p-value
Early arrival at hospital (≤4.5 h) 1.62 (1.04–2.52) 0.032 2.03 (1.04–3.96) 0.039
Age (years) 0.95 (0.94–0.97) 0.000 0.97 (0.95–0.99) 0.000
Education
    >13 years ref - -
    7–12 years 0.75 (0.45–1.26) 0.282 - -
    0–6 years 0.74 (0.45–1.22) 0.236 - -
Clear onset 1.93 (1.32–2.82) 0.001 1.41 (0.86–2.31) 0.169
Previous mRS score 0.45 (0.35–0.57) 0.000 0.52 (0.38–0.69) 0.000
Hypertension 1.30 (0.85–1.99) 0.221 - -
Diabetes mellitus 1.05 (0.71–1.55) 0.822 - -
Dyslipidemia 1.28 (0.88–1.86) 0.202 - -
Atrial fibrillation 1.71 (1.09–2.68) 0.020 1.01 (0.54–1.87) 0.981
Coronary artery disease 1.27 (0.76–2.13) 0.370 - -
Current smoker 0.58 (0.37–0.90) 0.016 1.48 (0.85–2.55) 0.163
Previous ischemic stroke or TIA 0.68 (0.45–1.03) 0.070 0.72 (0.42–1.24) 0.236
Previous use of antithromboticsb 0.75 (0.52–1.1) 0.136 - -
Acute thrombolysis therapy (IV-tPA or IAT) 0.54 (0.32–0.91) 0.020 2.09 (0.87–5.03) 0.101
Initial NIHSS score 0.79 (0.75–0.83) 0.000 0.77 (0.73–0.82) 0.000
Arrival at daytime 0.95 (0.58–1.56) 0.843 - -
Arrival at nighttime 1.03 (0.63–1.70) 0.898 - -

aAdjusted for arrival time at hospital, age, type of stroke onset time (clear- or unclear-onset strokes), previous mRS score, history of atrial fibrillation, smoking status, previous ischemic stroke or TIA, acute thrombolysis therapy, and initial NIHSS score.

bAntiplatelets and anticoagulation agents.

Abbreviations: OR, odds ratio; CI, confidence interval; mRS, modified Rankin Scale; TIA, transient ischemic stroke; IV, intravenous; tPA, tissue plasminogen activator; IAT, intra-arterial thrombectomy; NIHSS, National Institute of Health Stroke Scale.

Discussion

Our study demonstrated that patients who arrived at the hospital within 4.5 h of stroke onset had significantly lower three-month mRS scores after the stroke event than those who arrived after 4.5 h. Furthermore, the results of the multivariate analysis demonstrated that less severe stroke and pre-stroke disability, younger age, and early hospital arrival within 4.5 h of stroke onset were significant predictors of favorable clinical outcome (three-month mRS score: 0−2). Among these significant factors, early hospital arrival was the most prominent determinant of better prognosis even after adjusting for patients’ every other baseline characteristic. Previous studies have also confirmed that early hospital arrival within 1−6 h of stroke onset was an independent predictor for better prognosis regardless of patients’ demographic factors, conventional vascular risk factors, or stroke severity [1315]. However, these studies mostly credited the effect of reperfusion therapy for better outcomes in the early arrival group or did not distinguish patients who received IV-tPA or mechanical thrombectomy. In contrast, our study confirmed a favorable outcome of early arrivers even after adjusting for reperfusion therapy.

The findings of a recent multicenter Japanese study were also consistent with those of our study: early arrivers had a better clinical outcome regardless of reperfusion therapy [10]. In fact, our study has proven that early hospital arrival was associated with favorable clinical outcomes not only regardless of sociodemographic factors, conventional vascular risk factors, severity of a stroke, previous stroke or TIA, previous use of antithrombotics, pre-stroke disability, and receiving reperfusion therapies, but also regardless of the type of stroke onset (clear- or unclear-onset stroke). Thus, the importance of reporting to the hospital as soon as possible after recognizing stroke symptoms cannot be emphasized more in acute ischemic stroke patients.

Regarding the factors associated with delayed hospital arrival after ischemic stroke (>4.5 h), an additional multivariate analysis identified that lesser severity of the stroke, greater pre-stroke disability, female sex, unclear onset times, and low educational level with ≤6 years of schooling were significant factors that influenced late hospital arrival in acute ischemic stroke patients. The severity of the initial stroke significantly correlated with the onset-to-door time in our study because patients with lower NIHSS scores arrived notably later than those with higher scores. This may be because the greater severity of the stroke would have likely had a greater impact on the perceived urgency of patients or bystanders to take quick actions to visit the hospital for emergency care. Rosamond et al. reported that an increased sense of urgency by stroke patients for their symptoms positively influenced early hospital arrival [18]. Lesser severity has also been well established as a significant factor for late hospital arrival in several previous studies using various measures for severity [1926].

In contrast, greater pre-stroke disability, as estimated with the mRS, was markedly associated with late hospital arrival in our study, which was contrary to that of previous studies which reported that greater pre-stroke disability was associated with increased emergency medical service (EMS) use [27], or it was associated with an early hospital arrival [28]. The likelihood of increased physical and intellectual impairment in patients with a greater pre-stroke disability may explain our findings. Although patients with greater disability receive more EMSs, limited mobility or decreased cognitive function and other factors related to pre-stroke disability could have caused considerable delay in calling for EMSs, which contributed to the overall prehospital delay. A stroke registry-based study conducted by Madsen et al. also presented a similar trend as ours and interpreted their findings on this basis [29].

Interestingly, there was an association between sex difference and hospital arrival time in our study because women tended to arrive at the hospital later than men. According to Bergulund et al., women are generally older, have more impaired activities of daily living, and are more likely to live alone than men during stroke onset [30]. In fact, approximately 71% of the elderly living alone in Korea are women [31]. Additionally, when ischemic stroke patients are in contact with EMSs, the caller is usually their relative or friend rather than the patients themselves [32, 33]; hence, those living alone would obviously have more difficulty seeking emergent help. Previous studies have confirmed that living alone during stroke onset is a noticeable risk factor for late hospital arrival in acute ischemic stroke patients [33, 34]. As previously reported, female sex was also a risk factor for late hospital arrival in patients with ischemic stroke because women are more likely to be living alone than men [26, 35].

Another notable finding of our study was that unclear onset time of stroke was a significant predictor of late hospital arrival. To the best of our knowledge, our study is the first to examine the relationship between the type of stroke onset time (clear- or unclear-onset strokes) and onset-to-door time in acute ischemic stroke. Unclear-onset stroke occurs in patients who were asleep and who woke up with the presence of stroke symptoms (wake-up stroke) or patients who could not state the onset time owing to loss of consciousness but with no available witnesses [36], thus resulting in late hospital arrival. Our results identified that poorly educated patients with ≤6 years of schooling report to the hospital later than well-educated individuals with >12 years of schooling. Well-educated patients are more likely to be aware of the symptoms and signs that are indicative of acute ischemic stroke, which may have led them to promptly report to the hospital for urgent evaluation and management. This was consistent with the findings of previous studies that included patients with acute ischemic stroke or myocardial infarction [37, 38]. Thus, public education regarding the red flag symptoms of stroke and the importance of reporting early to the hospital should be implemented, especially to those with ≤6 years of schooling.

The strength of our study is that we analyzed data from two university tertiary hospitals with large stroke centers located in different areas of Seoul with different characteristics. Both the hospitals provided professional stroke care by experts according to the standard guidelines. Furthermore, we confirmed that early arrival in the hospital was an independent factor for a better clinical outcome regardless of potential confounders, including receiving reperfusion therapy and the type of stroke onset time (clear- or unclear-onset strokes). We also identified the predictors of late arrival, which provides an important reference for reducing pre-hospital delays.

However, our study has some limitations. First, other factors that may affect the onset-to-door time, such as distance from the place of stroke onset to the hospital and the type of transport system that patients used to report to the hospital, including EMS use, could not be included in the analysis owing to unavailability of data. Second, the onset-to-door time might have been overestimated in some patients, especially in those with unclear onset time, including those who had a wake-up stroke, since we defined the patients’ last neurologically normal time as the symptom onset time when the exact symptom onset time was unknown. Lastly, the patient cohort included in our study was mostly homogenous in terms of race and culture. Therefore, the findings of this study cannot be generalized, and further studies involving multiethnic and multicultural patients are needed to validate our findings.

Conclusions

In summary, early hospital arrival within 4.5 h after stroke onset was significantly associated with better clinical outcomes at three months after the event regardless of various baseline characteristics of patients, including the severity of the stroke, pre-stroke disability, receiving reperfusion therapies, and the type of stroke onset time (clear- or unclear-onset strokes). Furthermore, less severe stroke, greater pre-stroke disability, female sex, unclear onset times, and ≤6 years of schooling were independent factors that significantly affected late hospital arrival. Therefore, educating patients about the importance of early hospital arrival after acute ischemic stroke should be emphasized, and more strategic efforts are needed to reduce the prehospital delay by understanding the factors associated with a late arrival.

Supporting information

S1 Dataset. Minimal dataset.

(XLSX)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This research was supported by a fund (#2020ER620200) by the Korea Centers for Disease Control & Prevention, Republic of Korea (http://www.kdca.go.kr).

References

  • 1.Lees KR (2002) Management of acute stroke. The Lancet Neurology 1 (1):41–50 10.1016/s1474-4422(02)00005-4 [DOI] [PubMed] [Google Scholar]
  • 2.Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. (2014) Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. The Lancet 383 (9913):245–255 10.1016/s0140-6736(13)61953-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50 (12):e344–e418 10.1161/STR.0000000000000211 [DOI] [PubMed] [Google Scholar]
  • 4.Demaerschalk B, Kleindorfer D, Adeoye O, Demchuk A, Fugate J, Grotta J, et al. (2016) American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47 (2):581–641 10.1161/STR.0000000000000086 [DOI] [PubMed] [Google Scholar]
  • 5.Disorders NIoN, Group Sr-PSS (1995) Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine 333 (24):1581–1588 [DOI] [PubMed] [Google Scholar]
  • 6.de los Ríos la Rosa F, Khoury J, Kissela BM, Flaherty ML, Alwell K, Moomaw CJ, et al. (2012) Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III Trial. Stroke 43 (6):1591–1595 10.1161/STROKEAHA.111.645986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kim Y-J, Joon Kim B, Kwon SU, Kim JS, Kang D-W (2016) Unclear-onset stroke: Daytime-unwitnessed stroke vs. wake-up stroke. International Journal of Stroke 11 (2):212–220 10.1177/1747493015616513 [DOI] [PubMed] [Google Scholar]
  • 8.Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, et al. (2014) Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. The Lancet Neurology 13 (6):567–574 10.1016/S1474-4422(14)70066-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al. (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. The Lancet 384 (9958):1929–1935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Matsuo R, Yamaguchi Y, Matsushita T, Hata J, Kiyuna F, Fukuda K, et al. (2017) Association between onset-to-door time and clinical outcomes after ischemic stroke. Stroke 48 (11):3049–3056 10.1161/STROKEAHA.117.018132 [DOI] [PubMed] [Google Scholar]
  • 11.Evenson KR, Foraker R, Morris DL, Rosamond WD (2009) A comprehensive review of prehospital and in-hospital delay times in acute stroke care. International Journal of Stroke 4 (3):187–199 10.1111/j.1747-4949.2009.00276.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tong D, Reeves MJ, Hernandez AF, Zhao X, Olson DM, Fonarow GC, et al. (2012) Times from symptom onset to hospital arrival in the Get with the Guidelines–Stroke Program 2002 to 2009: temporal trends and implications. Stroke 43 (7):1912–1917 10.1161/STROKEAHA.111.644963 [DOI] [PubMed] [Google Scholar]
  • 13.Kwon YD, Yoon SS, Chang H (2010) Association of hospital arrival time with modified rankin scale at discharge in patients with acute cerebral infarction. European neurology 64 (4):207–213 10.1159/000319176 [DOI] [PubMed] [Google Scholar]
  • 14.Naganuma M, Toyoda K, Nonogi H, Yokota C, Koga M, Yokoyama H, et al. (2009) Early hospital arrival improves outcome at discharge in ischemic but not hemorrhagic stroke: a prospective multicenter study. Cerebrovascular Diseases 28 (1):33–38 10.1159/000215941 [DOI] [PubMed] [Google Scholar]
  • 15.Leon-Jimenez C, Ruiz-Sandoval J, Chiquete E, Vega-Arroyo M, Arauz A, Murillo-Bonilla L, et al. (2014) Hospital arrival time and functional outcome after acute ischaemic stroke: results from the PREMIER study. Neurología (English Edition) 29 (4):200–209 10.1016/j.nrl.2013.05.003 [DOI] [PubMed] [Google Scholar]
  • 16.Kang D-W, Sohn S-I, Hong K-S, Yu K-H, Hwang Y-H, Han M-K, et al. (2012) Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE) a prospective multicenter study. Stroke 43 (12):3278–3283 10.1161/STROKEAHA.112.675926 [DOI] [PubMed] [Google Scholar]
  • 17.Gorelick PB (2013) Primary and comprehensive stroke centers: history, value and certification criteria. Journal of stroke 15 (2):78 10.5853/jos.2013.15.2.78 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rosamond WD, Gorton RA, Hinn AR, Hohenhaus SM, Morris DL (1998) Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. Academic Emergency Medicine 5 (1):45–51 10.1111/j.1553-2712.1998.tb02574.x [DOI] [PubMed] [Google Scholar]
  • 19.Song D, Tanaka E, Lee K, Sato S, Koga M, Kim YD, et al. (2015) Factors associated with early hospital arrival in patients with acute ischemic stroke. Journal of stroke 17 (2):159 10.5853/jos.2015.17.2.159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fang J, Yan W, Jiang G-X, Li W, Cheng Q (2011) Time interval between stroke onset and hospital arrival in acute ischemic stroke patients in Shanghai, China. Clinical neurology and neurosurgery 113 (2):85–88 10.1016/j.clineuro.2010.09.004 [DOI] [PubMed] [Google Scholar]
  • 21.Jin H, Zhu S, Wei JW, Wang J, Liu M, Wu Y, et al. (2012) Factors associated with prehospital delays in the presentation of acute stroke in urban China. Stroke 43 (2):362–370 10.1161/STROKEAHA.111.623512 [DOI] [PubMed] [Google Scholar]
  • 22.Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J (2013) Streamlining of prehospital stroke management: the golden hour. The Lancet Neurology 12 (6):585–596 10.1016/S1474-4422(13)70100-5 [DOI] [PubMed] [Google Scholar]
  • 23.Turan TN, Hertzberg V, Weiss P, McClellan W, Presley R, Krompf K, et al. (2005) Clinical characteristics of patients with early hospital arrival after stroke symptom onset. Journal of Stroke and Cerebrovascular Diseases 14 (6):272–277 10.1016/j.jstrokecerebrovasdis.2005.07.002 [DOI] [PubMed] [Google Scholar]
  • 24.Jorgensen H, Nakayama H, Reith J, Raaschou H, Olsen T (1996) Factors delaying hospital admission in acute stroke: the Copenhagen Stroke Study. Neurology 47 (2):383–387 10.1212/wnl.47.2.383 [DOI] [PubMed] [Google Scholar]
  • 25.Faiz KW, Sundseth A, Thommessen B, Rønning OM (2013) Prehospital delay in acute stroke and TIA. Emergency Medicine Journal 30 (8):669–674 10.1136/emermed-2012-201543 [DOI] [PubMed] [Google Scholar]
  • 26.Le SM, Copeland LA, Zeber JE, Benge JF, Allen L, Cho J, et al. (2020) Factors affecting time between symptom onset and emergency department arrival in stroke patients. eNeurologicalSci:100285 10.1016/j.ensci.2020.100285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Adeoye O, Lindsell C, Broderick J, Alwell K, Jauch E, Moomaw CJ, et al. (2009) Emergency medical services use by stroke patients: a population-based study. The American journal of emergency medicine 27 (2):141–145 10.1016/j.ajem.2008.02.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Smith MA, Doliszny KM, Shahar E, McGovern PG, Arnett DK, Luepker RV (1998) Delayed hospital arrival for acute stroke: the Minnesota Stroke Survey. Annals of internal medicine 129 (3):190–196 10.7326/0003-4819-129-3-199808010-00005 [DOI] [PubMed] [Google Scholar]
  • 29.Madsen TE, Sucharew H, Katz B, Alwell KA, Moomaw CJ, Kissela BM, et al. (2016) Gender and time to arrival among ischemic stroke patients in the Greater Cincinnati/Northern Kentucky Stroke Study. Journal of Stroke and Cerebrovascular Diseases 25 (3):504–510 10.1016/j.jstrokecerebrovasdis.2015.10.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Berglund A, Schenck-Gustafsson K, von Euler M (2017) Sex differences in the presentation of stroke. Maturitas 99:47–50 10.1016/j.maturitas.2017.02.007 [DOI] [PubMed] [Google Scholar]
  • 31.Kim J, Song Y, Kim T, Park K (2019) Predictors of happiness among older Korean women living alone. Geriatrics & gerontology international 19 (4):352–356 10.1111/ggi.13615 [DOI] [PubMed] [Google Scholar]
  • 32.Berglund A, von Euler M, Schenck-Gustafsson K, Castrén M, Bohm K (2015) Identification of stroke during the emergency call: a descriptive study of callers’ presentation of stroke. BMJ open 5 (4) 10.1136/bmjopen-2015-007661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kothari R, Jauch E, Broderick J, Brott T, Sauerbeck L, Khoury J, et al. (1999) Acute stroke: delays to presentation and emergency department evaluation. Annals of emergency medicine 33 (1):3–8 10.1016/s0196-0644(99)70431-2 [DOI] [PubMed] [Google Scholar]
  • 34.Faiz KW, Sundseth A, Thommessen B, Rønning OM (2014) Factors related to decision delay in acute stroke. Journal of Stroke and Cerebrovascular Diseases 23 (3):534–539 10.1016/j.jstrokecerebrovasdis.2013.05.007 [DOI] [PubMed] [Google Scholar]
  • 35.Smith MA, Lisabeth LD, Bonikowski F, Morgenstern LB (2010) The role of ethnicity, sex, and language on delay to hospital arrival for acute ischemic stroke. Stroke 41 (5):905–909 10.1161/STROKEAHA.110.578112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wouters A, Lemmens R, Dupont P, Thijs V (2014) Wake-up stroke and stroke of unknown onset: a critical review. Frontiers in neurology 5:153 10.3389/fneur.2014.00153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rossnagel K, Jungehülsing GJ, Nolte CH, Müller-Nordhorn J, Roll S, Wegscheider K, et al. (2004) Out-of-hospital delays in patients with acute stroke. Annals of emergency medicine 44 (5):476–483 10.1016/j.annemergmed.2004.06.019 [DOI] [PubMed] [Google Scholar]
  • 38.Gibler WB, Armstrong PW, Ohman EM, Weaver WD, Stebbins AL, Gore JM, et al. (2002) Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. Annals of emergency medicine 39 (2):123–130 10.1067/mem.2002.121402 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Miguel A Barboza

25 Jan 2021

PONE-D-20-39466

Impact of Onset-to-Door Time on Outcomes and Factors Associated with Late Arrival in Acute Ischemic Stroke Patients

PLOS ONE

Dear Dr. Jeong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript is in general well written, but I encourage the authors to check for English Editing Services as there are some minor grammatical mistakes throughout the manuscript. Some minor issues from the methodological point of view, mainly in terms of covariates included in the multivariate analysis: did you perform a goodness of fit test when (such as Hosmer-Lemeshow) for correction of the final model? Also, did you pre-establish a p-value to include variables in the multivariate model, according to your pre-defined literature research?

Find attached also some suggestions from the 2 reviewers,

Please submit your revised manuscript by Mar 06 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Miguel A. Barboza, MD, MSc

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: We thank the authors for submitting their manuscript to the PLOS ONE Journal. The authors present a paper analysing clinical outcomes in acute ischemic stroke in a population with early vrs late hospital arrival independently from reperfusion therapy.

In spite of being a topic that has been published, at least partially, in the literature it is of significance and interest to our readers. The overall organization of the article is excellent. I do not feel any section should be expanded or shortened. The writing is clear, concise and all the sections reflect its main point of view. My overall impression is good.

The introduction is short but strong, providing an adequate background review of the literature related to the topic of the study. The main point of the article and hypothesis are clearly stated.

The abstract accurately reflects the paper.

The methods provided are valid for the question asked and are clearly presented so that this work could be replicated correctly. The statistical analysis was well done for the variables used. The sample size is ok and most of the variables analysed reach statistical significance. That said, bigger sample could always improve the significance and provide stronger evidence and validity of the study; especially for some of the vascular risk factors, such as dyslipidemia and diabetes, among others.

The authors´ results and data are clearly summarized and provided in tables and figures, which are necessary for the article. I do not see information needlessly repeated.

The discussion and conclusions were good, providing a powerful assessment of the results. Limitations were identified and explained.

The only figure was of moderate quality and could be improved. Both figure and tables were clearly labeled and titled.

The citations were pertinent and current. They all support assertions of fact that were not addressed by the data presented on the paper.

Reviewer #2: Dear Dr. HaeBong Jeong,

Thank you for permitting us to read your interesting manuscript.

This is a retrospective study of a prospective cohort, that investigated the impact of onset-to-door time on outcomes and predictors of pre-hospital delay after ischemic, including 539 patients from Seoul population, between 2019–2020. The conclusion was that early hospital arrival was significantly associated with favorable outcomes regardless of various confounders (reperfusion therapy, NIHSS, etc). It was a great effort, congratulations. Please consider the following comments.

1.- It should be important to mention in the methodology what is called “greater or lower pre-stroke disability”, in most cases we used a mRs 0-2 and 3-6, but this data should be clear in the study. The same case for NIHSS. I suggest that this difference also becomes noticeable in the tables, because according to this, it is the interpretation of the OR in them.

2.- In the discussion, I consider that it is more useful for the reader to know which mRS range predicts better outcomes (example 0-2, 3-6), more than the average mRS itself (example 0.33).

3.- The proposal made at the conclusion of the abstract is excellent, however, here the question of the title should also be answered. I suggest adding a statement that the onset to door time is important for prognosis and, briefly mentioning the factors involved in the arrival hospital delay, followed by your excellent education suggestion.

Thanks,

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Karla Alejandra Mora Rodriguez. Neurology Attending Physician. Epilepsy and Clinical Neurophysiology Subspecialty.

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 25;16(3):e0247829. doi: 10.1371/journal.pone.0247829.r002

Author response to Decision Letter 0


30 Jan 2021

Response to the Editor’s requests:

1. The manuscript is in general well written, but I encourage the authors to check for English Editing Services as there are some minor grammatical mistakes throughout the manuscript.

First of all, we apologize you for causing confusion. We have revised grammatical mistakes through English Editing Services as you recommended. Thank you for your thoughtful advice.

Please find the attached revised manuscript.

2. Some minor issues from the methodological point of view, mainly in terms of covariates included in the multivariate analysis: did you perform a goodness of fit test when (such as Hosmer-Lemeshow) for correction of the final model? Also, did you pre-establish a p-value to include variables in the multivariate model, according to your pre-defined literature research?

We would like to thank the editor for pointing this issue which has substantially helped us improve the methodology and overall quality of our study findings. Regarding the selection of covariates for the multivariate analyses of this study, we did perform Hosmer-Lemeshow goodness of fit test for each confounding variables for all of multivariate logistic regression analyses and the results demonstrated that there were no differences between observed and expected values as below, indicating that our models were suitable for regression analyses.

The results of Hosmer-Lemeshow test

1. Multivariate logistic regression analyses for factors associated with favorable outcome (3-month mRS score 0-2)

χ²: 5.016, p value: 0.756

2. Multivariate logistic regression analyses for factors associated with delayed onset-to-door time (>4.5h)

χ²: 5.628, p value: 0.689

In terms of pre-establishing a p-value to include variables in the multivariate model, we actually did not perform univariate analyses before conducting multivariate analyses. Thus we have performed univariate analyses and re-conducted multivariate analyses by including variables with p values < 0.1 in the univariate analyses to analyze adjusted odds ratios and 95% confidence intervals in accordance with your thoughtful advice. The overall tendency of new results was consistent with the initial results. We have revised our tables and “Results” section of our manuscript with newly attained results. Please find the attached revised manuscript.

We also revised the “Methods” section of our manuscript as below (newly added or revised contents are highlighted in yellow).

Predictors of delayed onset-to-door time and favorable outcomes

We included sex, age, educational status, the type of stroke onset time (clear- and unclear-onset strokes), medical histories (pre-stroke mRS score, comorbidities, previous stroke or TIA, previous use of antithrombotics, and smoking status), initial NIHSS score, and arrival time (daytime or nighttime) as potential factors that could affect the delayed onset-to-door time. Regarding the factors associated with favorable clinical outcome, age, educational status, the type of stroke onset time (clear- or unclear-onset strokes), medical histories (pre-stroke mRS score, comorbidities, previous stroke or TIA, previous use of antithrombotics and smoking status), initial NIHSS score, early hospital arrival (≤4.5 h), arrival time (daytime or nighttime), and receiving reperfusion therapy were included for the analysis. Both the pre-stroke mRS and initial NIHSS scores were included as continuous variables.

Statistical analyses

The characteristics and outcome variables were presented as numbers, percentages, and means with corresponding standard deviations. We performed the independent sample t-test or Mann-Whitney U test for continuous variables, and chi square test or Fisher's exact test for categorical variables to compare the characteristics and outcome variables between the early and late arrival groups. With delayed arrival to a hospital (>4.5 h) as the dependent variable, univariate analysis was performed, followed by an adjusted multivariate logistic regression analysis for investigating the predictors of pre-hospital delay. Furthermore, univariate and multivariate logistic regression analyses were performed to examine the association between early hospital arrival and favorable outcomes. We included variables with p-values <0.1 in the univariate analysis for the multivariate analysis. All statistical analyses were performed using SPSS version 25 (IBM Corp., Armonk, NY, USA). A two-sided p-value of <0.05 was considered statistically significant.

Response to the Reviewer #1’s comments:

1. We thank the authors for submitting their manuscript to the PLOS ONE Journal. The authors present a paper analysing clinical outcomes in acute ischemic stroke in a population with early vrs late hospital arrival independently from reperfusion therapy.

In spite of being a topic that has been published, at least partially, in the literature it is of significance and interest to our readers. The overall organization of the article is excellent. I do not feel any section should be expanded or shortened. The writing is clear, concise and all the sections reflect its main point of view. My overall impression is good.

The introduction is short but strong, providing an adequate background review of the literature related to the topic of the study. The main point of the article and hypothesis are clearly stated.

The abstract accurately reflects the paper.

The methods provided are valid for the question asked and are clearly presented so that this work could be replicated correctly. The statistical analysis was well done for the variables used. The sample size is ok and most of the variables analysed reach statistical significance. That said, bigger sample could always improve the significance and provide stronger evidence and validity of the study; especially for some of the vascular risk factors, such as dyslipidemia and diabetes, among others.

The authors´ results and data are clearly summarized and provided in tables and figures, which are necessary for the article. I do not see information needlessly repeated.

The discussion and conclusions were good, providing a powerful assessment of the results. Limitations were identified and explained.

We would like to thank the reviewer for such a kind words on our paper. We greatly appreciate all your valuable comments.

2. The only figure was of moderate quality and could be improved. Both figure and tables were clearly labeled and titled.

The citations were pertinent and current. They all support assertions of fact that were not addressed by the data presented on the paper.

We have revised the content and quality of our figure for better understanding of our selection process of study participants and to meet the publication standard for your journal. Please find the attached revised figure. Thank you for your thoughtful advice.

Response to Reviewer #2’s comments:

1. It should be important to mention in the methodology what is called “greater or lower pre-stroke disability”, in most cases we used a mRs 0-2 and 3-6, but this data should be clear in the study. The same case for NIHSS. I suggest that this difference also becomes noticeable in the tables, because according to this, it is the interpretation of the OR in them.

We would like to thank the reviewer for this precious comment, which points out important aspect of our study. We agree with you that in most cases pre-stroke mRS 0-2 is generally considered as lower pre-stroke disability whereas mRS 3-6 is regarded as greater pre-stroke disability. However, both the pre-stroke mRS and initial NIHSS scores were included as continuous variables rather than binary variables in all of our multivariable analyses. Thus, our results can be interpreted as the lower the initial NHISS score or the greater the pre-stroke mRS score the more delayed onset-to-door time for acute ischemic stroke patients. We have clarified this issue by adding a sentence in the “Methods” section (line 134 of page 7) of our study as below.

Both the pre-stroke mRS and initial NHISS scores were included as continuous variables.

2. In the discussion, I consider that it is more useful for the reader to know which mRS range predicts better outcomes (example 0-2, 3-6), more than the average mRS itself (example 0.33).

We appreciate the reviewer for this excellent comment which identifies essential perspective of our study. We agree with you that presenting mRS score with certain range when mentioning the effect of pre-stroke mRS score on the favorable outcome could be helpful for readers. However, as we mentioned in the previous question, pre-stroke mRS scores were included as continuous variables with average scores rather than binary variable with specific cut-off point. We believe our finding could be also meaningful since it indicates that the higher pre-stroke mRS predicts better clinical outcome regardless of good (mRS 0-2)/bad (mRS 3-6) status of pre-stroke mRS score.

3. The proposal made at the conclusion of the abstract is excellent, however, here the question of the title should also be answered. I suggest adding a statement that the onset to door time is important for prognosis and, briefly mentioning the factors involved in the arrival hospital delay, followed by your excellent education suggestion.

First of all, we would like to thank the reviewer for the positive comment on the conclusion part of our abstract. We would appreciate the reviewer’s thoughtful suggestion to add a statement that the onset to door time is important for prognosis and mentioning the identified factors influencing the pre-hospital delay as it has helped us to strengthen our conclusion. We have revised the conclusion of abstract (line 44 of page 2) as below to reflect your suggestion (newly added or revised contents are highlighted in yellow).

The onset-to-door time≤4.5h is crucial for better clinical outcome and less severe stroke, greater pre-stroke disability, female sex, unclear onset times, and ≤6 years of schooling were independent predictors of late arrival. Thus, educating about the importance of early hospital arrival after acute ischemic stroke should be emphasized. More strategic efforts are needed to reduce the pre-hospital delay by understanding the predictors of late arrival.

Decision Letter 1

Miguel A Barboza

15 Feb 2021

Impact of onset-to-door time on outcomes and factors associated with late hospital arrival in patients with acute ischemic stroke

PONE-D-20-39466R1

Dear Dr. Jeong,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Miguel A. Barboza, MD, MSc

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I currently have no comments for the authors on this re-review. On my previous comment I mentioned my overall impression was excellent and my only suggestion was to improve their one figure presented.

Reviewer #2: Dear Corresponding Author,

Thank you for taking the comments into account and making the pertinent changes.

I have no further comments, congratulations for this great effort.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Karla A. Mora R. MD. Neurology Attending Physician, Fellowship in Epilepsy

Reviewer #2: Yes: Vanessa Cano-Nigenda

Acceptance letter

Miguel A Barboza

1 Mar 2021

PONE-D-20-39466R1

Impact of onset-to-door time on outcomes and factors associated with late hospital arrival in patients with acute ischemic stroke

Dear Dr. Jeong:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Miguel A. Barboza

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Dataset. Minimal dataset.

    (XLSX)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES